BioChem - DOS

search

Search

Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain),

메타 데이터

바이오화학분류
    • 의료용 화학소재
      1. 치료제
CAS번호

331731-18-1

바이오화학 소재명

Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain),

바이오화학 소재명(일반명칭)

Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain),

화학식(MF)

C₂₀H₂₂N₂O₇S

물질 유래 분류

호르몬/효소/조효소

적용제품

바이오메디털 소재 (항암제)

총 190건의 특허가 있습니다.

1
자동차의 비상 경고장치
2023-12-11
2
Fed batch method of making anti-TNF-alpha antibodies
2023-12-11
3
Avian Transgenesis and Exogenous Proteins
2023-12-11
4
Glycosylated interferon alpha obtained from a transgenic chicken
2023-12-11
5
Methods of manufacturing therapeutic proteins
2023-12-11
6
PRODUCTION OF GLYCOPROTEINS
2023-12-11
7
A METHOD FOR PRODUCING A PRODUCT (E.G. POLYPEPTIDE) IN A CONTINUOUS CELL CULTURE FERMENTATION PROCESS.
2023-12-11
8
Cell culture improvement
2023-12-11
9
METHODS TO PRODUCE SINGLE GLYCOFORM ANTIBODIES
2023-12-11
10
METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING NON-COMMONLY USED SUGARS
2023-12-11
11
Cell culture process
2023-12-11
12
Method for purifying antibody
2023-12-11
13
METHODS AND COMPOSITIONS RELATED TO LARGE SCALE PRODUCTION OF PROTEINS
2023-12-11
14
MODULATION OF LIPID METABOLISM FOR PROTEIN PRODUCTION
2023-12-11
15
INHIBITION OF PROTEIN DEGRADATION FOR IMPROVED PRODUCTION
2023-12-11
16
Method of producing an exogenous protein in the egg of a chicken
2023-12-11
17
Composition comprising isolated human CTLA4-Fc fusion protein produced in a transgenic chicken
2023-12-11
18
Vectors containing magnum-specific promoters for avian transgenes
2023-12-11
19
CONTROL OF TOTAL AFUCOSYLATED GLYCOFORMS OF ANTIBODIES PRODUCED IN CELL CULTURE
2023-12-11
20
Glycosylated erythropoietin
2023-12-11
21
Mammalian expression vectors and uses thereof
2023-12-11
22
MODULATION OF LIPID METABOLISM FOR PROTEIN PRODUCTION
2023-12-11
23
METHOD FOR OBTAINING A GLYCOPROTEIN WITH AN INCREASED PERCENTAGE OF AFUCOSYLATED GLYCANS
2023-12-11
24
METHOD FOR QUANTIFYING HIGH MANNOSE CONTAINING GLYCOFORMS
2023-12-11
25
Method for producing a product (e.g. polypeptide) in a continuous cell culture fermentation process
2023-12-11
26
Cell culture improvements
2023-12-11
27
Vectors containing magnum-specific promoters for avian transgenes
2023-12-11
28
EXPRESSION OF MODIFIED GLYCOPROTEINS AND GLYCOPEPTIDES
2023-12-11
29
Modulation of lipid metabolism for protein production
2023-12-11
30
METHODS AND COMPOSITIONS RELATED TO LARGE SCALE PRODUCTION OF PROTEINS
2023-12-11
31
Expression of modified glycoproteins and glycopeptides
2023-12-11
32
Cell culture improvements
2023-12-11
33
CELL CULTURE PROCESS FOR PRODUCING A PROTEIN
2023-12-11
34
Mammalian expression vectors and uses thereof
2023-12-11
35
Inhibition of protein breakdown for improved production
2023-12-11
36
Method for secretory production of protein
2023-12-11
37
Transgenic birds and protein production in the egg white
2023-12-11
38
INHIBITION OF PROTEIN DEGRADATION FOR IMPROVED PRODUCTION
2023-12-11
39
Poultry Derived Glycosylated Interferon Alpha 2b
2023-12-11
40
Method for producing a product (e.g. polypeptide) in a continuous cell culture fermentation process
2023-12-11
41
Avian derived erythropoietin
2023-12-11
42
Production of exogenous proteins in egg whites of transgenic chickens
2023-12-11
43
Transgenic chickens producing exogenous protein in eggs
2023-12-11
44
METHODS OF MODULATING FUCOSYLATION OF GLYCOPROTEINS
2023-12-11
45
Cell culture improvements
2023-12-11
46
METHOD FOR CONTROLLING GALACTOSYLATION OF RECOMBINANT PROTEIN THROUGH OPTIMIZATION OF CULTURE MEDIUM
2023-12-11
47
Glycosylated G-CSF obtained from a transgenic chicken
2023-12-11
48
Avians that produce eggs containing exogenous proteins
2023-12-11
49
MODULATION OF LIPID METABOLISM FOR PROTEIN PRODUCTION
2023-12-11
50
EXPRESSION OF MODIFIED GLYCOPROTEINS AND GLYCOPEPTIDES
2023-12-11
51
METHODS AND COMPOSITIONS RELATED TO LARGE SCALE PRODUCTION OF PROTEINS
2023-12-11
52
PRODUCTION OF PROTEINS IN LABYRINTHULOMYCETES
2023-12-11
53
PRODUCTION OF PROTEINS IN LABYRINTHULOMYCETES
2023-12-11
54
MODULATION OF LIPID METABOLISM FOR PROTEIN PRODUCTION
2023-12-11
55
CELL CULTURE PROCESS FOR PRODUCING A PROTEIN
2023-12-11
56
A METHOD FOR PRODUCING A PRODUCT (E.G. POLYPEPTIDE) IN A CONTINUOUS CELL CULTURE FERMENTATION PROCESS.
2023-12-11
57
CELL CULTURE PROCESS FOR PRODUCING A PROTEIN
2023-12-11
58
METHODS TO PRODUCE SINGLE GLYCOFORM ANTIBODIES
2023-12-11
59
Use of perfusion seed culture to improve biopharmaceutical fed-batch production capacity and product quality
2023-12-11
60
PRODUCTION OF GLYCOPROTEINS
2023-12-11
61
Cell culture process
2023-12-11
62
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
2023-12-11
63
USE OF PERFUSION SEED CULTURES TO IMPROVE BIOPHARMACEUTICAL FED-BATCH PRODUCTION CAPACITY AND PRODUCT QUALITY
2023-12-11
64
기판의 결함 검사 장치, 기판의 결함 검사 방법 및 기억 매체
2023-12-11
65
Methods and compositions for enhanced expression and secretion of proteins
2023-12-11
66
Cell culture improvements
2023-12-11
67
PRODUCTION OF GLYCOPROTEINS
2023-12-11
68
METHODS FOR MODULATING PROTEIN GLYCOSYLATION PROFILES OF RECOMBINANT PROTEIN THERAPEUTICS USING COBALT
2023-12-11
69
High mannose glycans
2023-12-11
70
Methods of producing adalimumab
2023-12-11
71
Cell culture improvements
2023-12-11
72
Glycosylated human G-CSF
2023-12-11
73
RECOMBINANT ORGANISMS AND METHODS FOR PRODUCING GLYCOMOLECULES WITH HIGH GLYCAN OCCUPANCY
2023-12-11
74
METHODS FOR MODULATING PROTEIN GLYCOSYLATION PROFILES OF RECOMBINANT PROTEIN THERAPEUTICS USING COBALT
2023-12-11
75
ELIMINATION OF A CONTAMINATING NON-HUMAN SIALIC ACID BY METABOLIC COMPETITION
2023-12-11
76
Vectors containing magnum-specific promoters for avian transgenes
2023-12-11
77
Fed-batch method of making anti-TNF-alpha antibody
2023-12-11
78
Vectors containing magnum-specific promoters for avian transgenes
2023-12-11
79
Cell culture process
2023-12-11
80
CELL CULTURE IMPROVEMENTS
2023-12-11
81
Improving cell culture
2023-12-11
82
CONTROL OF TOTAL AFUCOSYLATED GLYCOFORMS OF ANTIBODIES PRODUCED IN CELL CULTURE
2023-12-11
83
Protein secretion production method
2023-12-11
84
GENETICALLY ENGINEERED EUKARYOTIC CELLS PRODUCING SIALYLATED GLYCOPROTEINS
2023-12-11
85
ELIMINATION OF A CONTAMINATING NON-HUMAN SIALIC ACID BY METABOLIC COMPETITION
2023-12-11
86
Fed-batch method of making human anti-TNF-alpha antibody
2023-12-11
87
METHODS TO PRODUCE SINGLE GLYCOFORM ANTIBODIES
2023-12-11
88
Novel Glycosylated Polypeptides
2023-12-11
89
Cell culture process for protein production
2023-12-11
90
EXPRESSION OF MODIFIED GLYCOPROTEINS AND GLYCOPEPTIDES
2023-12-11
91
IMPROVED PROCESS FOR PRODUCTION OF MONOCLONAL ANTIBODIES
2023-12-11
92
Improved process for production of monoclonal antibodies
2023-12-11
93
Method for manufacturing therapeutic proteins
2023-12-11
94
IMPROVED MAMMALIAN EXPRESSION VECTORS AND USES THEREOF
2023-12-11
95
태양광 발전용의 모듈화된 다이오드 방열판 조립체
2023-12-11
96
Use of perfusion seed culture to improve biopharmaceutical fed-batch production capacity and product quality
2023-12-11
97
CONTROL OF TOTAL AFUCOSYLATED GLYCOFORMS OF ANTIBODIES PRODUCED IN CELL CULTURE
2023-12-11
98
METHODS OF MODULATING FUCOSYLATION OF GLYCOPROTEINS
2023-12-11
99
Fed-batch methods for producing adalimumab
2023-12-11
100
METHOD FOR CONTROLLING GALACTOSYLATION OF RECOMBINANT PROTEIN THROUGH OPTIMIZATION OF CULTURE MEDIUM
2023-12-11
101
CELL CULTURE IMPROVEMENTS
2023-12-11
102
METHODS TO CONTROL PROTEIN HETEROGENEITY
2023-12-11
103
METHOD OF MANUFACTURING A THERAPEUTIC PROTEIN
2023-12-11
104
How to modulate galactosylation of recombinant proteins by optimizing culture media
2023-12-11
105
EXPRESSION OF MODIFIED GLYCOPROTEINS AND GLYCOPEPTIDES
2023-12-11
106
METHODS TO PRODUCE SINGLE GLYCOFORM ANTIBODIES
2023-12-11
107
INHIBITION OF PROTEIN DEGRADATION FOR IMPROVED PRODUCTION
2023-12-11
108
METHODS OF MODULATING FUCOSYLATION OF GLYCOPROTEINS
2023-12-11
109
Improved mammalian expression vectors and their uses
2023-12-11
110
CONTROL OF TOTAL AFUCOSYLATED GLYCOFORMS OF ANTIBODIES PRODUCED IN CELL CULTURE
2023-12-11
111
Glycosylated interferon alpha
2023-12-11
112
Cell culture process
2023-12-11
113
METHOD FOR PURIFYING ANTIBODY
2023-12-11
114
METHODS TO CONTROL PROTEIN HETEROGENEITY
2023-12-11
115
Modulation of lipid metabolism for protein production
2023-12-11
116
휴대용 빔 프로젝터 노트
2023-12-11
117
METHOD FOR PURIFYING ANTIBODY
2023-12-11
118
Improved mammalian expression vectors and their uses
2023-12-11
119
METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING SUGARS
2023-12-11
120
Cell culture improvements
2023-12-11
121
리튬 전지 및 상기 리튬 전지용 양극 활물질의 제조방법
2023-12-11
122
Production of proteins in labyrinthulomycetes
2023-12-11
123
커버글라스 및 이의 제조방법
2023-12-11
124
Immunoglobulin purification using pre-cleaning steps
2023-12-11
125
IMPROVED PROCESS FOR PRODUCTION OF MONOCLONAL ANTIBODIES
2023-12-11
126
췌장에서 발현되는 후각수용체 및 췌장소도 후각수용체 기반 글루카곤 조절을 이용한 당뇨병 예방 또는 치료용 조성물
2023-12-11
127
Cell culture improvements
2023-12-11
128
METHODS OF MANUFACTURING THERAPEUTIC PROTEINS
2023-12-11
129
Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product Quality
2023-12-11
130
METHOD FOR SECRETORY PRODUCTION OF PROTEINS
2023-12-11
131
Method for secretory production of protein
2023-12-11
132
High mannose glycans
2023-12-11
133
Regulation of total non-fucosylated glycoforms of antibodies produced in cell culture
2023-12-11
134
RECOMBINANT ORGANISMS AND METHODS FOR PRODUCING GLYCOMOLECULES WITH LOW SULFATION
2023-12-11
135
METHODS FOR CONTROLLING PROTEIN GLYCOSYLATION
2023-12-11
136
Cell culture improvements
2023-12-11
137
CELL CULTURE IMPROVEMENTS
2023-12-11
138
IMPROVED MAMMALIAN EXPRESSION VECTORS AND USES THEREOF
2023-12-11
139
IMPROVED PROCESS FOR PRODUCTION OF MONOCLONAL ANTIBODIES
2023-12-11
140
METHOD FOR SECRETORY PRODUCTION OF PROTEIN
2023-12-11
141
CELL CULTURE PROCESS
2023-12-11
142
USE OF PERFUSION SEED CULTURES TO IMPROVE BIOPHARMACEUTICAL FED-BATCH PRODUCTION CAPACITY AND PRODUCT QUALITY
2023-12-11
143
INHIBITION OF PROTEIN DEGRADATION FOR IMPROVED PRODUCTION
2023-12-11
144
Cell culture process for producing a protein
2023-12-11
145
Cell culture improvements
2023-12-11
146
METHODS TO CONTROL PROTEIN HETEROGENEITY
2023-12-11
147
Cell culture process
2023-12-11
148
METHODS FOR CONTROLLING THE GALACTOSYLATION PROFILE OF RECOMBINANTLY-EXPRESSED PROTEINS
2023-12-11
149
METHODS FOR CONTROLLING PROTEIN GLYCOSYLATION
2023-12-11
150
Cell culture improvements
2023-12-11
151
METHODS OF MANUFACTURING THERAPEUTIC PROTEINS
2023-12-11
152
HIGH MANNOSE GLYCANS
2023-12-11
153
METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING SUGARS
2023-12-11
154
METHODS FOR CONTROLLING THE GALACTOSYLATION PROFILE OF RECOMBINANTLY-EXPRESSED PROTEINS
2023-12-11
155
Improved method for producing monoclonal antibodies
2023-12-11
156
IMMUNOGLOBULIN PURIFICATION USING PRE-CLEANING STEPS
2023-12-11
157
GENETICALLY ENGINEERED EUKARYOTIC CELLS PRODUCING SIALYLATED GLYCOPROTEINS
2023-12-11
158
Modified serum-free cell culture medium
2023-12-11
159
DOUBLE KNOCK-OUT CHO CELL LINE METHOD OF ITS GENERATION AND PRODUCING THERAPEUTIC PROTEINS THEREFROM
2023-12-11
160
METHOD FOR MODULATING GALACTOSYLATION OF RECOMBINANT PROTEIN THROUGH OPTIMIZATION OF CULTURE MEDIUM
2023-12-11
161
Improving cell culture
2023-12-11
162
Methods of producing anti-TNF-alpha antibodies in mammalian cell culture
2023-12-11
163
Immunoglobulin purification using pre-cleaning steps
2023-12-11
164
CELL CULTURE IMPROVEMENTS
2023-12-11
165
Fed-batch method of making human anti-TNF-alpha antibody
2023-12-11
166
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
2023-12-11
167
Fed-batch cell culture methods using non-animal-based hydrolysates
2023-12-11
168
CELL CULTURE IMPROVEMENTS
2023-12-11
169
Expression of modified glycoproteins and glycopeptides
2023-12-11
170
MAMMALIAN EXPRESSION VECTORS AND USES THEREOF
2023-12-11
171
IMMUNOGLOBULIN PURIFICATION USING PRE-CLEANING STEPS
2023-12-11
172
Improved mammalian expression vectors and uses thereof
2023-12-11
173
비말동반 현상 방지를 위한 분리 장치
2023-12-11
174
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
2023-12-11
175
Cell culture improvements
2023-12-11
176
METHOD OF MANUFACTURING A THERAPEUTIC PROTEIN
2023-12-11
177
METHODS FOR CONTROLLING THE GALACTOSYLATION PROFILE OF RECOMBINANTLY-EXPRESSED PROTEINS
2023-12-11
178
MODULATION OF METABOLIC PATHWAYS FOR IMPROVING BIOPROCESS PERFORMANCE AND SECRETED PROTEIN PRODUCTIVITY OF YEAST
2023-12-11
179
IMMUNOGLOBULIN PURIFICATION USING PRE-CLEANING STEPS
2023-12-11
180
Purification of immunoglobulins using a pre-cleaning step
2023-12-11
181
METHODS FOR CONTROLLING THE GALACTOSYLATION PROFILE OF RECOMBINANTLY-EXPRESSED PROTEINS
2023-12-11
182
Improved mammalian expression vectors and uses thereof
2023-12-11
183
METHOD FOR CONTROLLING THE AFUCOSYLATION LEVEL OF A GLYCOPROTEIN COMPOSITION
2023-12-11
184
CELL CULTURE IMPROVEMENTS
2023-12-11
185
METHOD FOR OBTAINING A GLYCOPROTEIN WITH AN INCREASED PERCENTAGE OF AFUCOSYLATED GLYCANS
2023-12-11
186
Improving cell culture
2023-12-11
187
CELL CULTURE PROCESS
2023-12-11
188
소셜 커머스 기반의 타겟팅 상품 할인정보 제공 시스템 및 방법
2023-12-11
189
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
2023-12-11
190
How to modulate galactosylation of recombinant proteins by optimizing culture media
2023-12-11

총 1건의 무역이 있습니다.

1
면역물품(혼합하지 않은 것에 한정하며, 일정한 투여량으로 한 것, 소매용 모양이나 포장을 한 것은 제외한다)
2023-12-11

총 0건의 후보군 물질이 있습니다.

뒤로가기

후보군 물질; 2023-12-11

Export
PDF

본원 (우)34141 대전광역시 유성구 대학로 245 한국과학기술정보연구원

042) 869-1004,1234042) 869-0969

분원 (우)02456 서울특별시 동대문구 회기로 66 한국과학기술정보연구원

02) 3299-6114 02) 3299-6244
Copyright © 한국과학기술정보연구원. All Rights Reserved.

About

Search

Trend